Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
Business Wire•26/10/2026•16:01 ET
0
Key Highlights
- ➤Arcturus (ARCT) will report Q3 2026 financial results November 5 after market close
- ➤Corporate update and earnings conference call scheduled for November 5 at 4:30 p.m. ET
- ➤Pipeline includes programs targeting cystic fibrosis, OTC deficiency, PKU and Gout
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory therapeutics, today announced that it will release its financial results for the quarter ended September 30, 2026, after the market close on Thursday, November 5(th) and will also host a conference call and webcast at 4:30 pm Eastern Time on November 5, 2026.
Get started
Create a free account to read the full story.